Pharmacologic Therapies for Management of Crohn's Disease: Comparative Effectiveness - Final Report
Friday, February 28, 2014
Posted by: Becky Dryden
The Agency for Healthcare Research and Quality (AHRQ) released their research review on Crohn's Disease entitled Pharmacologic Therapies for the Management of Crohn's Disease: Comparative Effectiveness on February 25, 2014.
Visit the AHRQ and find the full pdf report here: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1869
View the report here: http://effectivehealthcare.ahrq.gov/ehc/products/192/1869/Crohns-Disease-report-140225.pdf
Objectives of the Report: "The purpose of this review was to compare the efficacy and safety of biologics, immunomodulators, corticosteroids, and aminosalicylates in the treatment of Crohn's disease."
Citation: Hutfless S, Almashat, S, Berger Z, Wilson LM, Bonson E, Chen Q, Donath E, Herlong F, Puhan MA, Selvaraj S, Tuskey A, Vasilescu A, Bass EB, Worthington M, Palamaner G, Lazarev M. Pharmacologic Therapies for the Management of Crohn’s Disease: Comparative Effectiveness. Comparative Effectiveness Review No. 131. (Prepared by Johns Hopkins Evidence-based Practice Center under Contract No. 290-2007-10061-I.) AHRQ Publication No. 14-EHC012-EF. Rockville, MD: Agency for Healthcare Research and Quality; February 2014. www.effectivehealthcare.ahrq.gov/reports/final.cfm.